| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 07/09/2009 | WO2009085584A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists |
| 07/09/2009 | WO2009085185A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 07/09/2009 | US20090176858 Hcv protease inhibitors and uses thereof |
| 07/09/2009 | US20090176307 Compounds, Compositions and Methods |
| 07/09/2009 | DE60019555C5 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit 2-oxy-benzoxazinonderivate for treatment of obesity |
| 07/09/2009 | CA2709202A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
| 07/08/2009 | EP2076518A1 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
| 07/08/2009 | EP2076512A1 Fused thiazole derivatives as kinase inhibitors |
| 07/08/2009 | EP2076133A2 Synthesis of enone intermediate |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/07/2009 | US7557207 Spiro 2,4-pyrimidinediamine compounds and their uses |
| 07/07/2009 | US7557125 Fab I inhibitors |
| 07/07/2009 | US7557120 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 07/07/2009 | US7557114 Heterocyclic-substituted phenyl methanones |
| 07/07/2009 | US7557100 Antibacterial agents |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/02/2009 | WO2009082437A2 Selective androgen receptor modulators (sarms) and uses thereof |
| 07/02/2009 | WO2009081959A1 Process for production of 4-(substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one |
| 07/02/2009 | WO2009081460A1 Spirooxazine radical derivatives and reversible isomerization reaction |
| 07/02/2009 | WO2009080533A1 Heteroaryl derivatives as orexin receptor antagonists |
| 07/02/2009 | WO2009080182A1 Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas |
| 07/02/2009 | WO2009051820A3 Use of oxazine compounds for making chromogenic materials |
| 07/02/2009 | WO2009013545A3 Chemical compounds |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | US20090170172 Recombinant Methods and Materials for Producing Epothilone and Epothilone Derivatives |
| 07/02/2009 | US20090169567 Basic group-containing compound and use thereof |
| 07/02/2009 | CA2710485A1 Process for production of 4-(substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one |
| 07/02/2009 | CA2710113A1 Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas |
| 07/02/2009 | CA2709677A1 Selective androgen receptor modulators (sarms) and uses thereof |
| 07/02/2009 | CA2705411A1 Heteroaryl derivatives as orexin receptor antagonists |
| 07/01/2009 | EP1747221B1 Fused ring nk1 antagonists |
| 07/01/2009 | CN100506823C Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 06/30/2009 | US7553866 3-(2-Oxo-tetrahydrothiopyran-3-yl)propionic acid; inhibiting the prostrate specific antigen;angiogenesis inhibition; compulsive disorder, neuropathy, analgesics, anticarcinogenic agents; Huntinton's disease; antidiabetic agents; retinopathy; gluacoma; effecting transforming growth factor, glutamate |
| 06/30/2009 | US7553848 Vanilloid receptor ligands and their use in treatments |
| 06/30/2009 | US7553843 Process for the preparation of purified crystalline CCI-779 |
| 06/30/2009 | US7553842 Topically active FK520 and FK506 analogs; calcineurin inhibitorse useful in the treatment of immunoregulatory and respiratory disorders; lung or heart transplantation; antiinflammatory agents; bronchitis; asthma; immunosuppressants; autoimmune diseases eosinophil-related diseases |
| 06/25/2009 | US20090163563 Phorboxazole Compounds and Methods of Their Preparation |
| 06/25/2009 | US20090163537 Thienopyridinone Compounds and Methods of Treatment |
| 06/25/2009 | US20090163473 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES |
| 06/25/2009 | US20090162413 Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices |
| 06/25/2009 | DE102007061763A1 Substituierte azabicyclische Verbindungen und ihre Verwendung Substituted azabicyclic compounds and their use |
| 06/24/2009 | EP2072512A1 Herbicide compounds based on N-Azinyl-N'-pyridylsulfonyl-ureas |
| 06/24/2009 | EP1954698B1 Spirocyclic compounds as hdac inhibitors |
| 06/24/2009 | EP1863812A4 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550442 For therapy of subject infected with a retrovirus |
| 06/18/2009 | WO2009076337A1 Gamma secretase modulators |
| 06/18/2009 | WO2009046841A3 Piperidine and piperazine derivatives for treating tumours |
| 06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090156627 Therapeutic compounds |
| 06/18/2009 | US20090156578 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents |
| 06/18/2009 | US20090156577 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 06/18/2009 | CA2708151A1 Gamma secretase modulators |
| 06/18/2009 | CA2708140A1 Curable benzoxazine macromonomers, their preparation and cured products thereof |
| 06/18/2009 | CA2708081A1 Curable benzoxazine-based compositions, their preparation and cured products thereof |
| 06/17/2009 | EP2070933A1 Tricyclic triazolic compounds |
| 06/17/2009 | EP2069363A1 Rifaximin |
| 06/17/2009 | EP2069362A1 Process for preparing n-alkyl naltrexone halides |
| 06/17/2009 | EP2069353A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 06/17/2009 | EP2068904A1 Methods for preparing diazonamides |
| 06/17/2009 | CN101460504A Tricyclic oxazepines as in vivo imaging compounds |
| 06/16/2009 | US7547782 Met kinase inhibitors |
| 06/16/2009 | US7547692 Rifamycin analogs and uses thereof |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/11/2009 | WO2009073779A1 Gamma secretase modulators |
| 06/11/2009 | WO2009073777A1 Gamma secretase modulators |
| 06/11/2009 | WO2009073669A1 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions |
| 06/11/2009 | WO2009073534A2 Bicyclic ppat inhibitors as antibacterial agents |
| 06/11/2009 | WO2009071657A1 Tricyclic triazolic compounds |
| 06/11/2009 | WO2009032123A3 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 06/11/2009 | WO2008129004A3 Heterocyclic compounds containing the morpholine nucleus their preparation and use |
| 06/11/2009 | US20090149526 Tetracyclic Indole Derivatives as Antiviral Agents |
| 06/11/2009 | US20090149514 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149453 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 06/11/2009 | CA2708022A1 Tricyclic triazolic compounds |
| 06/11/2009 | CA2707722A1 Gamma secretase modulators |
| 06/11/2009 | CA2707712A1 Gamma secretase modulators |
| 06/10/2009 | EP2067775A1 Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors |
| 06/10/2009 | EP2066679A1 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 06/10/2009 | EP2066678A1 Spiro antibiotic derivatives |
| 06/10/2009 | EP2066677A1 Pyridooxazepine progesteron receptor modulators |
| 06/10/2009 | EP2066647A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
| 06/10/2009 | EP1601673B1 Fused heterocycles and uses thereof |
| 06/10/2009 | EP1599461B1 THIOLACTONES AS NAALADase INHIBITORS |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | CN100497346C Chemokine CCR5 receptor modulators |
| 06/10/2009 | CN100497345C 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis |
| 06/09/2009 | US7544697 Pyrazolopyridines and analogs thereof |
| 06/09/2009 | US7544695 N-(2-Aminophenyl)-6-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)nicotinamide; inhibit histone deacetylase, selectively induce terminal differentiation and arresting cell growth and/or apoptosis of neoplastic cells; increased bioavailability |
| 06/04/2009 | WO2009040817A3 Salarins and tulearins, compositions and uses thereof |
| 06/04/2009 | WO2009035634A3 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
| 06/04/2009 | US20090143577 Purification of progesterone receptor modulators |
| 06/04/2009 | US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |